NGM Biopharmaceuticals Inc (DELISTED) (NGM:DL)
1.54
0.00 (0.00%)
USD |
NASDAQ |
Apr 05, 16:00
NGM Biopharmaceuticals Profit Margin (Quarterly): -16.77K% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -16.77K% |
| September 30, 2023 | -4.95K% |
| June 30, 2023 | -2.69K% |
| March 31, 2023 | -2.12K% |
| December 31, 2022 | -200.4% |
| September 30, 2022 | -597.4% |
| June 30, 2022 | -560.9% |
| March 31, 2022 | -154.9% |
| December 31, 2021 | -129.9% |
| September 30, 2021 | -155.4% |
| June 30, 2021 | -218.8% |
| March 31, 2021 | -127.7% |
| Date | Value |
|---|---|
| December 31, 2020 | -141.6% |
| September 30, 2020 | -126.8% |
| June 30, 2020 | -129.7% |
| March 31, 2020 | -78.46% |
| December 31, 2019 | -51.29% |
| September 30, 2019 | -50.62% |
| June 30, 2019 | -30.26% |
| March 31, 2019 | -32.36% |
| December 31, 2018 | 30.06% |
| September 30, 2018 | -36.11% |
| June 30, 2018 | -14.47% |
| March 31, 2018 | -21.17% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-16.77K%
Minimum
Dec 2023
-30.26%
Maximum
Jun 2019
-1.54K%
Average
-154.9%
Median
Mar 2022
Profit Margin (Quarterly) Benchmarks
| Catalent Inc | -9.40% |
| AIM ImmunoTech Inc | -14.54K% |
| Perspective Therapeutics Inc | -- |
| Protalix BioTherapeutics Inc | -122.6% |
| Armata Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -71.83% |
| Return on Assets | -62.02% |
| Return on Invested Capital | -71.83% |
| Operating Margin (Quarterly) | -17.98K% |
| Return on Net Operating Assets | -1.33K% |